ARCHIVES

Challoner: We Recommended FDA Replace 510(k) Clearance

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

Newest NIH Institute, NIBIB, Gets An Acting Director.

May 11, 2001

NCI forms pediatric central IRB.

July 30, 2004

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

August 9, 1991

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

New Abiraterone Acetate Results Show Greater Benefit Than Before

June 24, 2011

NCI Plans Program To Help Academics With Initial Stages of Drug Discovery.

November 30, 2007